C12N 2770/36143
Viral genome or elements thereof as genetic vector
Official title: viral genome or elements thereof as genetic vector
C12N2770/36143 (Viral genome or elements thereof as genetic vector) appears on 294 US grants and 480 published applications in this corpus.
Search patents in C12N- Granted patents
- 294
- Published applications
- 480
- Assignees
- 167
- Inventors
- 623
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 3 | 0 |
| 1997 | 1 | 0 |
| 1998 | 4 | 0 |
| 1999 | 5 | 0 |
| 2000 | 7 | 0 |
| 2001 | 8 | 2 |
| 2002 | 12 | 8 |
| 2003 | 9 | 18 |
| 2004 | 6 | 15 |
| 2005 | 1 | 12 |
| 2006 | 9 | 14 |
| 2007 | 6 | 10 |
| 2008 | 8 | 14 |
| 2009 | 9 | 14 |
| 2010 | 9 | 15 |
| 2011 | 4 | 16 |
| 2012 | 8 | 11 |
| 2013 | 6 | 15 |
| 2014 | 9 | 16 |
| 2015 | 3 | 8 |
| 2016 | 7 | 10 |
| 2017 | 7 | 9 |
| 2018 | 8 | 10 |
| 2019 | 5 | 11 |
| 2020 | 6 | 31 |
| 2021 | 15 | 21 |
| 2022 | 25 | 45 |
| 2023 | 38 | 57 |
| 2024 | 24 | 44 |
| 2025 | 16 | 36 |
| 2026 | 12 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cytokine immunotherapy22 Sep 2026US 12,742,182 B2VLP Therapeutics, LLC
- Prostate neoantigens and their uses28 Jul 2026US 12,692,513 B2Janssen Biotech, Inc.
- Alphavirus neoantigen vectors and interferon inhibitors16 Jun 2026US 12,653,883 B2Seattle Project Corp.
- Galectin-targeting immunotherapy26 May 2026US 12,636,341 B2VLP Therapeutics, LLC
- Swine influenza A virus vaccine comprising two distinct RNA replicon particles26 May 2026US 12,636,359 B2Intervet Inc.
- Treatment of atopic dermatitis using self-replicating rna expressing il-3120 Aug 2026US 2026/0240967 A1Ceva Sante Animale
- Multiepitope vaccine cassettes30 Jul 2026US 2026/0216307 A1Seattle Project Corp.
- Swine influenza a virus vaccine comprising a nucleic acid construct having a specific order of genes30 Jul 2026US 2026/0217771 A1Intervet Inc.
- Modified madariaga viruses, self-replicating rna constructs, and uses thereof30 Jul 2026US 2026/0218170 A1Replicate Bioscience, Inc.
- Gene delivery system and application thereof in preparation of drugs for treatment of tumors9 Jul 2026US 2026/0191798 A1Shanghai Cell Diff Medicine Ltd.
Most cited
By later US patents
- Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes185US 5,316,931 ABiosource Genetics Corporation · 1994
- Method of inducing an immune response with a live Venezuelan Equine Encephalitis virus expressing a heterologous immunogen123US 5,643,576 AThe University of North Carolina at Chapel Hill · 1997
- Composition and methods for transfecting eukaryotic cells122US 5,578,475 ALife Technologies Corporation · 1996
- Sindbis virus vectors105US 5,091,309 AWashington University · 1992
- Recombinant plant viral nucleic acids105US 5,589,367 ABiosource Technologies, Inc. · 1996